Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Matthews

Showing results (901-910 of 930) with videos related to

Pageof 93
Sort By:
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
Scientific Reports|June 17, 2022
Mid-pregnancy poly(I:C) viral mimic disrupts placental ABC transporter expression and leads to long-term offspring motor and cognitive dysfunctionV R S Monteiro, C B V Andrade, H R Gomes, et al.
Contemporary Clinical Trials|September 3, 2014
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials NetworkErin A McClure, Susan C Sonne, Theresa Winhusen, et al.
The Journal of Infectious Diseases|November 15, 2025
Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis BS J Hume, K Visvanathan, K Cheng, et al.
The Journal of Physiology|April 11, 2018
Guinea pig models for translation of the developmental origins of health and disease hypothesis into the clinicJanna L Morrison, Kimberley J Botting, Jack R T Darby, et al.
Addiction (Abingdon, England)|March 8, 2016
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) studyWalter Ling, Maureen P Hillhouse, Andrew J Saxon, et al.
JAMA Neurology|November 25, 2024
Neuropsychological Outcomes in 6-Year-Old Children of Women With Epilepsy: A Prospective Nonrandomized Clinical TrialKimford J Meador, Morris J Cohen, David W Loring, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 10, 2020
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)Cary D Austin, Melissa Gonzalez Edick, Ronald E Ferrando, et al.
The European Respiratory Journal|September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthmaJohn Busby, John G Matthews, Rekha Chaudhuri, et al.
JAMA Network Open|April 5, 2023
Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use DisorderGail D'Onofrio, E Jennifer Edelman, Kathryn F Hawk, et al.
Pageof 93

Showing results (901-910 of 930) with videos related to

Sort By:
Pageof 93
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
Scientific Reports|June 17, 2022
Mid-pregnancy poly(I:C) viral mimic disrupts placental ABC transporter expression and leads to long-term offspring motor and cognitive dysfunctionV R S Monteiro, C B V Andrade, H R Gomes, et al.
Contemporary Clinical Trials|September 3, 2014
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials NetworkErin A McClure, Susan C Sonne, Theresa Winhusen, et al.
The Journal of Infectious Diseases|November 15, 2025
Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis BS J Hume, K Visvanathan, K Cheng, et al.
The Journal of Physiology|April 11, 2018
Guinea pig models for translation of the developmental origins of health and disease hypothesis into the clinicJanna L Morrison, Kimberley J Botting, Jack R T Darby, et al.
Addiction (Abingdon, England)|March 8, 2016
Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) studyWalter Ling, Maureen P Hillhouse, Andrew J Saxon, et al.
JAMA Neurology|November 25, 2024
Neuropsychological Outcomes in 6-Year-Old Children of Women With Epilepsy: A Prospective Nonrandomized Clinical TrialKimford J Meador, Morris J Cohen, David W Loring, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 10, 2020
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)Cary D Austin, Melissa Gonzalez Edick, Ronald E Ferrando, et al.
The European Respiratory Journal|September 25, 2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthmaJohn Busby, John G Matthews, Rekha Chaudhuri, et al.
JAMA Network Open|April 5, 2023
Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use DisorderGail D'Onofrio, E Jennifer Edelman, Kathryn F Hawk, et al.
Pageof 93